Brian Boyles's Colleagues at QED Therapeutics
Brian Boyles's Contact Details
HQ
650-231-4088
650-231-4088
Location
Morgantown, West Virginia, United States
Morgantown, West Virginia, United States
Company
QED Therapeutics
QED Therapeutics
Brian Boyles's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Brian Boyles
Brian Boyles currently works for QED Therapeutics.
Brian Boyles's role at QED Therapeutics is Senior Quality Assurance Manager.
Brian Boyles's email address is ***@qedtx.com. To view Brian Boyles's full email address, please signup to ConnectPlex.
Brian Boyles works in the BioTech/Drugs industry.
Brian Boyles's colleagues at QED Therapeutics are Richard Jones II, Edward Oliva, Sudesh PhD, Quoc M., Ai Li, Craig Berman, Elena Muslimova and others.
Brian Boyles's phone number is 650-231-4088